CardioVascular and Interventional Radiology (CVIR) is an official journal of
the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
Founded in 1978 by Professors Herbert L. Abrams and Eberhard Zeitler,
CVIR is the longest-running journal in the field of vascular and interventional radiology.
CIRSE Members have unlimited online access to all CVIR articles. To access the full text articles, log in with the credentials for myCIRSE.
TARE and immunotherapy for ICC : Combined analysis from the CIRT and the CIRT-FR multicentre observational studies on 174 patients revealed that a first line treatment with TARE and any systemic treatment appears beneficial in terms of overall survival. Partition model dosimetry is also a predictor of better outcome. The heterogeneity however, of the real-world study population needs to be taken into account.
Endoleaks represent the most common complication after EVAR. Some types are associated with ongoing risk of aneurysm rupture and necessitate long-term surveillance and secondary interventions, and this SOP provides up-to-date recommendations for its safe performance.
Optimize your article with the new feature in CVIR! Submit a visual abstract of your paper in addition to the textual abstract, to highlight your research and findings. All article types are eligible, with the exception of editorials, letters to the editor and commentaries. Click here to download the template.
We are happy to announce CVIR’s 2022 impact factor which increased to 2.9! This achievement underscores the exceptional quality and importance of the articles published in the journal. A big thank you to the journal’s dedicated authors, reviewers, editors, and readers for their invaluable contributions and support.
CVIR’s November issue features a special section on MSK interventions curated by world-renown expert in the field: Julien Garnon.
This special section presents the latest technical advancements and most significant data from the literature on hot topics in MSK. The goal is to give any IR an overview of what is feasible and
for which result.
Thank you to those who submitted their application. We are currently in the process of reviewing them and candidates will be contacted soon.
Are you about to submit your paper to CVIR?
Click here to find out which biological/biomedical reporting checklists are mandatory when submitting to CVIR.
CIRSE has a journal family!
Good papers submitted to CVIR and not accepted due to CVIR's limited page budget will be offered transfer to CVIR Endovascular for consideration.
2-year impact factor |
2.9 | |
5-year impact factor |
2.6 | |
Downloads in 2022 |
591,937 | |
Days to first decision (2022 median) |
5 days |